Your browser doesn't support javascript.
loading
An overview on pure autonomic failure.
Pavy-Le Traon, A; Foubert-Samier, A; Fabbri, M.
Afiliação
  • Pavy-Le Traon A; Neurology department, French reference center for Multiple System Atrophy, CHU de Toulouse, Toulouse, France; I2MC Institute-Inserm U1297, Toulouse, France.
  • Foubert-Samier A; Bordeaux University, Inserm, Bordeaux Population Health Research Center, UMR1219, Bordeaux, France; Neurodegenerative Diseases Neurology Department, CHU de Bordeaux, IMNc, CRMR AMS, Bordeaux, France; Bordeaux University, CNRS, IMN, UMR 5293, Bordeaux, France.
  • Fabbri M; Neurology department, French reference center for Multiple System Atrophy, CHU de Toulouse, Toulouse, France; Department of Clinical Pharmacology and Neurosciences, Toulouse Parkinson Expert Centre, Toulouse NeuroToul Center of Excellence in Neurodegeneration (COEN), French NS-Park/F-CRIN Network, University of Toulouse 3, CHU of Toulouse, Inserm, Toulouse, France.
Rev Neurol (Paris) ; 180(1-2): 94-100, 2024.
Article em En | MEDLINE | ID: mdl-38129276
ABSTRACT
Pure autonomic failure (PAF) is a neurodegenerative disease affecting the sympathetic component of the autonomic nervous system and presenting as orthostatic hypotension (OH). It is a rare, sporadic disease of adults. Although OH is the primary symptom, the autonomic dysfunction may be more generalised, leading to genitourinary and intestinal dysfunction and sweating disorders. Autonomic symptoms in PAF may be similar to those observed in other autonomic neuropathies that need to be ruled out. PAF belongs to the group of α synucleinopathies and is characterised by predominant peripheral deposition of α-synuclein in autonomic ganglia and nerves. However, in a significant number of cases, PAF may convert into another synucleinopathy with central nervous system involvement with varying prognosis Parkinson's disease (PD), multiple system atrophy (MSA), or dementia with Lewy bodies (DLB). The clinical features, the main differential diagnoses, the risk factors for "phenoconversion" to another synucleinopathy as well as an overview of treatment will be discussed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doenças do Sistema Nervoso Autônomo / Atrofia de Múltiplos Sistemas / Doença por Corpos de Lewy / Insuficiência Autonômica Pura / Sinucleinopatias Limite: Adult / Humans Idioma: En Revista: Rev Neurol (Paris) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doenças do Sistema Nervoso Autônomo / Atrofia de Múltiplos Sistemas / Doença por Corpos de Lewy / Insuficiência Autonômica Pura / Sinucleinopatias Limite: Adult / Humans Idioma: En Revista: Rev Neurol (Paris) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França